Prior to founding ImmBio, Dr Colaço was Director of Intellectual Property (IP) for the biotechnology company Quadrant Healthcare plc, where he was responsible for development of the IP portfolio that formed the basis of its successful Chapter 20 listing on the London Stock Exchange and subsequent acquisition by Elan. In addition to his industry experience, Dr Colaço has worked in a number of leading institutions, including the University of Cambridge, CALTECH, ICRF and EMBL. He has a 1st Class Hons degree in Biochemistry from the University of London and a PhD from the NIMR, Mill Hill. ImmunoBiology was founded on his seminal proposal of the Central Role of the Dendritic Cell in the integration of Innate and Acquired Immunity.